Tech Company Financing Transactions

Gemelli Biotech Funding Round

On 6/22/2022, Gemelli Biotech raised $19 million in Series A funding from Blue Ox Healthcare Partners, Carolina Angel Network and Cedars-Sinai Medical Center.

Transaction Overview

Company Name
Announced On
6/22/2022
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series A
Proceeds Purpose
Gemelli will use the capital raised to accelerate the commercialization of its trio-smart and ibs-smart precision diagnostic tests, including expanding sales and marketing across the US and the scale-up of laboratory and manufacturing capacity, as well as its operational footprints in Raleigh and Los Angeles.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
911 North West St. 207
Raleigh, NC 27603
USA
Phone
Undisclosed
Email Address
Overview
To leverage leading biological discoveries related to the microbiome to provide non-invasive precision diagnostics which enable clinicians to definitively detect scientifically validated biomarkers and optimally treat GI diseases including SIBO, IMO, excess hydrogen sulfide and post-infectious IBS.
Profile
Gemelli Biotech LinkedIn Company Profile
Social Media
Gemelli Biotech Company Twitter Account
Company News
Gemelli Biotech News
Facebook
Gemelli Biotech on Facebook
YouTube
Gemelli Biotech on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Matthew Mitcho
  Matthew Mitcho LinkedIn Profile  Matthew Mitcho Twitter Account  Matthew Mitcho News  Matthew Mitcho on Facebook
Chief Marketing Officer
Aniruddh Pandit
  Aniruddh Pandit LinkedIn Profile  Aniruddh Pandit Twitter Account  Aniruddh Pandit News  Aniruddh Pandit on Facebook
VP - Bus. Development
Fab Wilfong
  Fab Wilfong LinkedIn Profile  Fab Wilfong Twitter Account  Fab Wilfong News  Fab Wilfong on Facebook
VP - Customer Service
Jim Dodson
  Jim Dodson LinkedIn Profile  Jim Dodson Twitter Account  Jim Dodson News  Jim Dodson on Facebook
VP - Finance
Todd Krzyzaniak
  Todd Krzyzaniak LinkedIn Profile  Todd Krzyzaniak Twitter Account  Todd Krzyzaniak News  Todd Krzyzaniak on Facebook
VP - Marketing
Barbra Dillon
  Barbra Dillon LinkedIn Profile  Barbra Dillon Twitter Account  Barbra Dillon News  Barbra Dillon on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/22/2022: Prime Trust venture capital transaction
Next: 6/22/2022: Electric Hydrogen venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

Our team works diligently to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary